The BCG replacement vaccine VPM1002: from drawing board to clinical trial (Q38202181)

30 August 2017

The BCG replacement vaccine VPM1002: from drawing board to clinical trial (English)

1 reference

30 August 2017

Martin Gengenbacher

4

0 references

Gerhard Walzl

object named as

Gerhard Walzl

7

0 references

Stefan Kaufmann

object named as

Stefan He Kaufmann

1

0 references

author name string

Mark F Cotton

2

1 reference

30 August 2017

Bernd Eisele

3

1 reference

30 August 2017

Leander Grode

5

1 reference

30 August 2017

Anneke C Hesseling

6

1 reference

30 August 2017

7 April 2014

1 reference

Expert Review of Vaccines

30 August 2017

1 reference

30 August 2017

13

1 reference

30 August 2017

619-630

1 reference

30 August 2017

5

1 reference

Creative Commons Attribution 4.0 International

30 August 2017

start time

7 April 2014

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

1 reference

April 2022 Public Data File from Crossref

cites work

Immunological biomarkers of tuberculosis

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.905746

New insights into the function of granulomas in human tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.905746

Floating between the poles of pathology and protection: can we pin down the granuloma in tuberculosis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.905746

Mycobacterium tuberculosis: success through dormancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.905746

The immune response in tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.905746

Short-term and long-term risk of tuberculosis associated with CD4 cell recovery during antiretroviral therapy in South Africa

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.905746

CD4(+) regulatory T cells in a cynomolgus macaque model of Mycobacterium tuberculosis infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.905746

An antimicrobial activity of cytolytic T cells mediated by granulysin

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.905746

Tuberculosis vaccines: time to think about the next generation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.905746

Vaccines against tuberculosis: where are we and where do we need to go?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.905746

Recombinant live vaccine candidates against tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.905746

Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.905746

Molecular analysis of genetic differences between Mycobacterium bovis BCG and virulent M. bovis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.905746

A historical and molecular phylogeny of BCG strains.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.905746

Identification of variable regions in the genomes of tubercle bacilli using bacterial artificial chromosome arrays

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.905746

Genome plasticity of BCG and impact on vaccine efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.905746

Dissection of ESAT-6 system 1 of Mycobacterium tuberculosis and impact on immunogenicity and virulence

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.905746

A protein secretion pathway critical for Mycobacterium tuberculosis virulence is conserved and functional in Mycobacterium smegmatis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.905746

ESX/type VII secretion systems and their role in host-pathogen interaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.905746

The BCG World Atlas: a database of global BCG vaccination policies and practices

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.905746

The changing profile of pediatric meningitis at a referral centre in Cape Town, South Africa

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.905746

Disseminated bacille Calmette-Guérin disease in HIV-infected South African infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.905746

Bacillus Calmette-Guérin (BCG) vaccine-induced complications in children treated with highly active antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.905746

Early antiretroviral treatment reduces risk of bacille Calmette-Guérin immune reconstitution adenitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.905746

Randomized trial of BCG vaccination at birth to low-birth-weight children: beneficial nonspecific effects in the neonatal period?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.905746

Small randomized trial among low-birth-weight children receiving bacillus Calmette-Guérin vaccination at first health center contact

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.905746

Non-specific effects of BCG?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.905746

Bacille Calmette-Guerin induces NOD2-dependent nonspecific protection from reinfection via epigenetic reprogramming of monocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.905746

The non-specific effects of vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.905746

The in vitro evolution of BCG vaccines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.905746

Actin-dependent movement of bacterial pathogens

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.905746

Mycobacterium bovis Bacille Calmette-Guérin strains secreting listeriolysin of Listeria monocytogenes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.905746

The family of thiol-activated, cholesterol-binding cytolysins

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.905746

Increased vaccine efficacy against tuberculosis of recombinant Mycobacterium bovis bacille Calmette-Guérin mutants that secrete listeriolysin

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.905746

Apoptotic vesicles crossprime CD8 T cells and protect against tuberculosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.905746

The recombinant tuberculosis vaccine rBCG ΔureC::hly(+) induces apoptotic vesicles for improved priming of CD4(+) and CD8(+) T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.905746

Recombinant BCG ΔureC hly+ induces superior protection over parental BCG by stimulating a balanced combination of type 1 and type 17 cytokine responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.905746

Inborn errors of interferon (IFN)-mediated immunity in humans: insights into the respective roles of IFN-alpha/beta, IFN-gamma, and IFN-lambda in host defense

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.905746

Nonclinical Development of BCG Replacement Vaccine Candidates

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.905746

Safety and immunogenicity of the recombinant BCG vaccine VPM1002 in a phase 1 open-label randomized clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.905746

21 January 2018

Global cancer statistics

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.905746

EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder: update 2013.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.905746

Bacillus Calmette-Guérin treatment of non-muscle invasive bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.905746

Role of neutrophils in BCG immunotherapy for bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.905746

Novel recombinant BCG expressing perfringolysin O and the over-expression of key immunodominant antigens; pre-clinical characterization, safety and protection against challenge with Mycobacterium tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.905746

A PEST-like sequence in listeriolysin O essential for Listeria monocytogenes pathogenicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.905746

Taking a New Shot At a TB Vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.905746

Recombinant bacillus calmette-guerin (BCG) vaccines expressing the Mycobacterium tuberculosis 30-kDa major secretory protein induce greater protective immunity against tuberculosis than conventional BCG vaccines in a highly susceptible animal model

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.905746

A new recombinant bacille Calmette-Guérin vaccine safely induces significantly enhanced tuberculosis-specific immunity in human volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.905746

Construction, characterization and preclinical evaluation of MTBVAC, the first live-attenuated M. tuberculosis-based vaccine to enter clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.905746

Safety and efficacy of MVA85A, a new tuberculosis vaccine, in infants previously vaccinated with BCG: a randomised, placebo-controlled phase 2b trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.905746

Protective immune responses to a recombinant adenovirus type 35 tuberculosis vaccine in two mouse strains: CD4 and CD8 T-cell epitope mapping and role of gamma interferon

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.905746

A human type 5 adenovirus-based tuberculosis vaccine induces robust T cell responses in humans despite preexisting anti-adenovirus immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.905746

A multistage tuberculosis vaccine that confers efficient protection before and after exposure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.905746

Exchanging ESAT6 with TB10.4 in an Ag85B fusion molecule-based tuberculosis subunit vaccine: efficient protection and ESAT6-based sensitive monitoring of vaccine efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.905746

Ag85B-ESAT-6 adjuvanted with IC31 promotes strong and long-lived Mycobacterium tuberculosis specific T cell responses in naïve human volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.905746

A randomized, controlled dose-finding Phase II study of the M72/AS01 candidate tuberculosis vaccine in healthy PPD-positive adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.905746

Improved CD4⁺ T cell responses to Mycobacterium tuberculosis in PPD-negative adults by M72/AS01 as compared to the M72/AS02 and Mtb72F/AS02 tuberculosis candidate vaccine formulations: a randomized trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.905746

A defined tuberculosis vaccine candidate boosts BCG and protects against multidrug-resistant Mycobacterium tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.905746

Production of unmarked mutations in mycobacteria using site-specific recombination.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.905746

The tuberculosis vaccine candidate Bacillus Calmette-Guérin ΔureC::hly coexpressing human interleukin-7 or -18 enhances antigen-specific T cell responses in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.905746

Lysosomal cell death at a glance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.905746

Endocytosis mechanisms and the cell biology of antigen presentation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.905746

Rational design of vaccines against tuberculosis directed by basic immunology

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.905746

Mycobacterium tuberculosis nuoG is a virulence gene that inhibits apoptosis of infected host cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.905746

Enhanced priming of adaptive immunity by a proapoptotic mutant of Mycobacterium tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.905746

SecA2 functions in the secretion of superoxide dismutase A and in the virulence of Mycobacterium tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.905746

A role for IL-18 in protective immunity against Mycobacterium tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.905746

Interleukin-7 or interleukin-15 enhances survival of Mycobacterium tuberculosis-infected mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.905746

Interleukin-7: biology and potential clinical applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.905746

Caspase-1 processes IFN-gamma-inducing factor and regulates LPS-induced IFN-gamma production.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.905746

Cloning of a new cytokine that induces IFN-gamma production by T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.905746

Vitamin B6 biosynthesis is essential for survival and virulence of Mycobacterium tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.905746

A pantothenate auxotroph of Mycobacterium tuberculosis is highly attenuated and protects mice against tuberculosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.905746

Attenuation of and protection induced by a leucine auxotroph of Mycobacterium tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.905746

Vaccine efficacy of a lysine auxotroph of Mycobacterium tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.905746

Human T-cell responses to 25 novel antigens encoded by genes of the dormancy regulon of Mycobacterium tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.905746

Evaluation of a nutrient starvation model of Mycobacterium tuberculosis persistence by gene and protein expression profiling

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.905746

Transcriptional Adaptation of Mycobacterium tuberculosis within Macrophages: Insights into the Phagosomal Environment

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.905746

Application of mycobacterial proteomics to vaccine design: improved protection by Mycobacterium bovis BCG prime-Rv3407 DNA boost vaccination against tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.905746

Improved long-term protection against Mycobacterium tuberculosis Beijing/W in mice after intra-dermal inoculation of recombinant BCG expressing latency associated antigens.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.905746

Recombinant Mycobacterium bovis BCG as an HIV vaccine vector

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.905746

Recombinant Mycobacterium bovis bacillus Calmette-Guérin secreting merozoite surface protein 1 (MSP1) induces protection against rodent malaria parasite infection depending on MSP1-stimulated interferon gamma and parasite-specific antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.905746

A recombinant Bacille Calmette-Guérin construct expressing the Plasmodium falciparum circumsporozoite protein enhances dendritic cell activation and primes for circumsporozoite-specific memory cells in BALB/c mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.905746

Recombinant bacille Calmette-Guérin priming against measles

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.905746

Immunisation with recombinant BCG expressing the cottontail rabbit papillomavirus (CRPV) L1 gene provides protection from CRPV challenge

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.905746

Protective humoral response against pneumococcal infection in mice elicited by recombinant bacille Calmette-Guérin vaccines expressing pneumococcal surface protein A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.905746

Protective immunity elicited by recombinant bacille Calmette-Guerin (BCG) expressing outer surface protein A (OspA) lipoprotein: a candidate Lyme disease vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.905746

Heterologous prime-boost regimen adenovector 35-circumsporozoite protein vaccine/recombinant Bacillus Calmette-Guérin expressing the Plasmodium falciparum circumsporozoite induces enhanced long-term memory immunity in BALB/c mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.905746

The heparin-binding haemagglutinin of M. tuberculosis is required for extrapulmonary dissemination.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.905746

Increased interleukin-18 content and angiogenic activity of sera from diabetic (Type 2) patients with background retinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.905746

IL-23 and IL-17 in the establishment of protective pulmonary CD4+ T cell responses after vaccination and during Mycobacterium tuberculosis challenge

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.905746

10.1586/14760584.2014.905746

21 January 2018

Identifiers

DOI

1 reference

30 August 2017

1 reference